Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of changes, notices of special interest NOSI, and funding opportunities.
Policy Notices
- AHRQ Grant Recipient use of the eRA Commons to Submit First-Time No-Cost Extension (NCE) Notifications for Grant Awards that are under Expanded Authorities
Agency for Healthcare Research and Quality
- Notice to Extend PA-17-246
Agency for Healthcare Research and Quality
General Notices
- Notice of Pre-Application Webinar for Developmental Genotype-Tissue Expression Project (dGTEx)
National Human Genome Research Institute
- Request for Information (RFI) on Flexibilities for Conducting Semiannual Animal Facility Inspections
National Institutes of Health
Notice of Changes to Funding Opportunities
- Notice of Early Expiration of PAR-20-269 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
National Institute on Aging
- Notice of Change to Award Information in PAR-19-242, Paul Calabresi Career Development for Clinical Oncology (K12 Clinical Trial Optional)
National Cancer Institute
- Notice of Correction to PAR-20-221, "NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of Change to the Application Instructions for the Candidate Eligibility Statement in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
National Institute of General Medical Sciences
- Notice to Reduce the Number of Research Projects Required in PAR-19-313 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)"
National Institute of General Medical Sciences
- Notice to Reduce the Number of Research Projects Required in PAR-19-312 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)"
National Institute of General Medical Sciences
- Notice of NHLBI Participation in NOT-OD-20-097 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences"
National Heart, Lung, and Blood Institute
- Notice of Expiration of NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials"
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
National Heart, Lung, and Blood Institute
- RESCINDED - Notice of NHLBI Participation in NOT-OD-20-119 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
National Heart, Lung, and Blood Institute
- RESCINDED - Notice of NHLBI Participation in NOT-OD-20-120 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
National Heart, Lung, and Blood Institute
- RESCINDED - Notice of NHLBI Participation in NOT-OD-20-121 "Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
National Heart, Lung, and Blood Institute
- Notice of Change: Extension to end date for NOT-OD-20-130 RFI: Enhancing Rigor, Transparency, and Translatability to Improve Biomedical Research Involving Animal Models
National Institutes of Health
- Notice of Change: Clarification of Budget for PA-20-227 "Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)"
Office of Dietary Supplements
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute on Minority Health and Health Disparities
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for New Cohorts to Assess Environmental Exposures and Cancer Risk (UG3/UH3 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for a Coordinating Center for New Cohorts to Assess Environmental Exposures and Cancer Risk (U24 Clinical Trial Not Allowed)
National Cancer Institute
Requests for Proposal
- Request for Proposal (RFP) Notice: NHLBI Progenitor Cell Translational Consortium (PCTC) - Scientific Services to Conduct In-depth Cell Characterization for the NIH Regenerative Medicine Innovation Project 2020
National Heart, Lung, and Blood Institute
Notices of Special Interest
- Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD)
National Institute on Aging
- Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Biomedical Imaging and Bioengineering
Funding Opportunities
- Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
- Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Cancer Institute
National Human Genome Research Institute
National Institute of Dental and Craniofacial Research
- NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
National Cancer Institute
- Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
- Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Cancer Institute
National Institute of Environmental Health Sciences
Office of Disease Prevention
Office of Research on Women's Health
- Limited Competition for the Continuation of the Look AHEAD (Action for Health in Diabetes) Study (U01 Clinical Trial Not Allowed)
National Institute on Aging -
Extension of the World Trade Center Health Registry (U50)
National Institute for Occupational Safety and Health
- Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
John E. Fogarty International Center
National Institute of Environmental Health Sciences
- Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
- Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
- NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional)
- Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional)
- Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed)
- Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu